Michael Verneris, MD
Professor, Pediatrics-Heme/Onc and Bone Marrow Transplantation

Professor of Pediatrics
Director of Bone Marrow Transplantation and Cellular Therapy
The Barton Family Endowed Chair of Bone Marrow Transplant
Co-Director, Tumor Host Interactions Program, Colorado Cancer Center
Translational Sciences Lead, Gates Institute
Clinic 720-777-1234
Print Profile
Email Profile
Featured Provider Photo

Gender: Male
Languages: English
Department, Section/Division: Pediatrics-Heme/Onc and Bone Marrow Transplantation

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234
More providers at this location

Hospital Affiliation
  • Children's Hospital Colorado

Specialty Information

Specialties
  • Pediatrics - Pediatric Hematology / Oncology, Board Certification
Clinical Interest for Patients
My clinical and laboratory interests are in the area of leukemia and in using the immune system to treat cancer, whether that be through bone marrow transplantation or cellular immunotherapy.

Care Philosophy
My care philosophy is to, first and foremost, be honest and forthright with information. I believe that it only in this way that parents and patients can make the best decisions about their care. I also try to engage both the family and the patient in the decision making process when it is possible and appropriate.

Personal Interests
I enjoy spending time watching my kids play hockey and lacrosse. I also enjoy listening to great music and eating good food.

Education & Training

Medical Schools:
  • MD, Dartmouth Medical School (1992)

Undergraduate Schools:
  • BS, Syracuse University (NY) (1987)

Internships:
  • Children's National Medical Center/George Washington University Program (1992)

Residency Program:
  • Children's National Medical Center/George Washington University Program, Pediatric Hematology / Oncology (1995)

Fellowships:
  • Stanford Hospital and Clinics Program, Pediatric Hematology / Oncology (1998)

Research & Grants

Grants
  • Targeting Pediatric Sarcoma with Bispecific Toxins and Immune System Engagers (2015)
    Hyundai Hope on Wheels, $82672
  • Genetic Epidemiology of Hematopoietic Cell Transplant Outcomes (2015)
    NIH/NCI, $405138
  • Biomarkers in Pediatric Versus Adult Myelodysplastic Syndromes (2015)
    NIH/NCI, $50000
  • Lymphoid Tissue Inducer/NK22 Cells and Post-Transplant Immune Recovery (2013)
    NIH/NIAID, $250000
Research interests for Patients:
My laboratory focuses on developing genetically modified T cells, specifically CAR T cells, to effectively target solid tumors. Our research aims to enhance CAR T cell homing, survival, and function within the tumor microenvironment, overcoming key barriers to their efficacy. By optimizing these properties, we seek to improve therapeutic outcomes and advance next-generation immunotherapies for solid tumors.

Information for Referring Providers

Clinical Interests for Referring Providers
My clinical interests include the use of allogeneic transplantation for acute leukemia and the development and testing of cellular therapy (CAR T cells and Natural Killer cells) to prevent leukemia relapse

Research Interest for Referring Providers
My laboratory focuses on developing genetically modified T cells, specifically CAR T cells, to effectively target solid tumors. Our research aims to enhance CAR T cell homing, survival, and function within the tumor microenvironment, overcoming key barriers to their efficacy. By optimizing these properties, we seek to improve therapeutic outcomes and advance next-generation immunotherapies for solid tumors.
Lab Phone: (303) 724-4006